Happitech

Happitech, a Dutch medical technology company founded in 2015, provides a software-based solution for heart health monitoring. The company was established by Yosef Safi Harb, an aerospace and mechatronics engineer, who was personally motivated by his father's struggle with an undiagnosed heart condition. This experience drove him to apply his engineering and AI expertise to create accessible medical-grade technology. Headquartered in Rotterdam, Netherlands, the company has navigated six years of clinical studies and regulatory approvals to refine its offering.

Happitech's core business revolves around its Software Development Kit (SDK), a CE-marked and TGA-approved Class IIa medical device. This SDK allows technology partners, such as healthcare app developers and telehealth companies, to integrate heart health monitoring directly into their existing platforms. The business model is centered on licensing these algorithms to telemonitoring and healthcare companies. By offering its technology as an SDK, Happitech enables other health app providers to incorporate medical-grade monitoring without lengthy regulatory delays. The company serves a range of clients, including healthcare providers, technology partners, and clinical researchers, and has established strategic partnerships with major names like Siemens, Roche, and AstraZeneca.

The primary service is a hardware-free technology that uses a smartphone's camera and flash to measure heart rhythm. This is achieved through photoplethysmography (PPG), a non-invasive technique that detects changes in blood volume. Users place a fingertip on the phone's camera for 60-90 seconds to get a measurement. The company's AI-powered algorithms analyze the PPG waveforms to deliver clinically validated measurements of heart rate, heart rate variability, and atrial fibrillation (AFib) with high sensitivity and specificity. This allows for the early detection and long-term monitoring of cardiac arrhythmias, a condition that affects one in eleven people over 65 and can significantly increase the risk of stroke and heart failure if left untreated. The platform has been deployed in over 50% of Dutch cardiology hospitals and is expanding into the UK and US markets, with FDA approval pending.

Keywords: cardiac monitoring, remote patient monitoring, digital health, MedTech, photoplethysmography, PPG, atrial fibrillation, AFib detection, heart rate variability, healthcare SDK, CE-certified medical device, TGA-approved, Yosef Safi Harb, telehealth, mobile health, heart rhythm, cardiovascular disease, clinical decision support, preventative medicine, virtual wards, population health